These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32391660)

  • 1. [Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19].
    Zhang X; Sun W; Shang S; Mao J; Fu J; Shu Q; Jiang K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(2):170-177. PubMed ID: 32391660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan.
    Chen CC; Chi CY
    Cancer Cytopathol; 2020 May; 128(5):309-316. PubMed ID: 32259402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
    Reifel KM; Swan BK; Jellison ER; Ambrozak D; Baijer J; Nguyen R; Monard S; Lyon G; Fontes B; Perfetto SP
    Cytometry A; 2020 Jul; 97(7):674-680. PubMed ID: 32488957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COVID-19 pandemic: implications for the cytology laboratory.
    Pambuccian SE
    J Am Soc Cytopathol; 2020; 9(3):202-211. PubMed ID: 32284276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Laboratory Risk Assessment during the Coronavirus (COVID-19) Pandemic.
    Nichols JH; Rauch CA
    J Appl Lab Med; 2020 Jul; 5(4):808-811. PubMed ID: 32529229
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
    Wang K; Zhu X; Xu J
    Health Secur; 2020; 18(3):232-236. PubMed ID: 32522074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The standard for handling of accidental leak coronavirus disease 2019 sample (T/BPMA 0005-2020)].
    Beijing Preventive Medicine Association
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Sep; 41(9):1370-1372. PubMed ID: 33076585
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists.
    Misra V; Agrawal R; Kumar H; Kar A; Kini U; Poojary A; Chakrabarti I; Rai S; Singhal A; Shankar SV; Iyengar JN
    Indian J Pathol Microbiol; 2020; 63(3):350-357. PubMed ID: 32769321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposable customized aerosol containment chamber for oral cancer biopsy: A novel technique during COVID-19 pandemic.
    Sharma SS; Singh DK; Yadav AK; Swain J; Kumar S; Jain DK; Prakash P
    J Surg Oncol; 2020 Aug; 122(2):120-121. PubMed ID: 32394482
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Iwen PC; Stiles KL; Pentella MA
    Lab Med; 2020 May; 51(3):239-242. PubMed ID: 32275309
    [No Abstract]   [Full Text] [Related]  

  • 11. Cautious handling of urine from moderate to severe COVID-19 patients.
    Nomoto H; Ishikane M; Katagiri D; Kinoshita N; Nagashima M; Sadamasu K; Yoshimura K; Ohmagari N
    Am J Infect Control; 2020 Aug; 48(8):969-971. PubMed ID: 32502614
    [No Abstract]   [Full Text] [Related]  

  • 12. Urological recommendations regarding surgical care of suspected or confirmed SARS-CoV-2 or COVID-19 + patients.
    Esteban M; Prieto L; Álvarez-Ossorio JL; Gómez A; Cortiñas JR; Serrano A; Cózar JM
    Actas Urol Esp (Engl Ed); 2020; 44(6):383-385. PubMed ID: 32576407
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronavirus Disease 2019 Prevention Strategy in the Emergency Department: Specimen Collection in a Negative-Pressure Outdoor Chamber.
    Lai PF; Chen KC; Chiang HL; Tseng FC; Wu PA
    Ann Emerg Med; 2020 Sep; 76(3):371-373. PubMed ID: 32828335
    [No Abstract]   [Full Text] [Related]  

  • 14. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
    Lippi G; Adeli K; Ferrari M; Horvath AR; Koch D; Sethi S; Wang CB
    Clin Chem Lab Med; 2020 Jun; 58(7):1053-1062. PubMed ID: 32396137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission and prevention of SARS-CoV-2.
    Wang Z; Fu Y; Guo Z; Li J; Li J; Cheng H; Lu B; Sun Q
    Biochem Soc Trans; 2020 Oct; 48(5):2307-2316. PubMed ID: 33084885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.
    Hussain Gardezi SA; Ikram A
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S48-S51. PubMed ID: 32515375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection and disinfection policies against SARS-CoV-2 (COVID-19).
    Fathizadeh H; Maroufi P; Momen-Heravi M; Dao S; Köse Ş; Ganbarov K; Pagliano P; Esposito S; Kafil HS
    Infez Med; 2020 Ahead of print Jun 1; 28(2):185-191. PubMed ID: 32275260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China.
    Yuan D; Gao W; Liang S; Yang S; Jia P
    Environ Int; 2020 Oct; 143():105964. PubMed ID: 32768807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. India under COVID-19 lockdown.
    The Lancet
    Lancet; 2020 Apr; 395(10233):1315. PubMed ID: 32334687
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples.
    Pastorino B; Touret F; Gilles M; Luciani L; de Lamballerie X; Charrel RN
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32521706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.